Tae Won Kim

Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial

Jin Li, Shukui Qin, Rui‐Hua Xu et al. · The Lancet Oncology · 2015 · 816 citations

Medicine, Oncology, Pharmacotherapy +10

Single-Agent Divarasib (GDC-6036) in Solid Tumors with a <i>KRAS</i> G12C Mutation

Adrian G. Sacher, Patricia LoRusso, Manish R. Patel et al. · New England Journal of Medicine · 2023 · 294 citations · Full text

Medicine, Oncology, Pharmacology +16

Pembrolizumab for previously treated, microsatellite instability–high/mismatch repair–deficient advanced colorectal cancer: final analysis of KEYNOTE-164

Dung T. Le, Luis A. Díaz, Tae Won Kim et al. · European Journal of Cancer · 2023 · 93 citations

Medicine, Biomedical Sciences, Oncology +12

Abstract CT302: Phase Ia/Ib dose-escalation study of the anti-TIGIT antibody tiragolumab as a single agent and in combination with atezolizumab in patients with advanced solid tumors

Johanna C. Bendell, Philippe L. Bédard, Yung‐Jue Bang et al. · Cancer Research · 2020 · 64 citations

Life Sciences, Immunology, Oncology +17

Randomized Phase II Open-Label Study of mFOLFOX6 in Combination With Linifanib or Bevacizumab for Metastatic Colorectal Cancer

Bert H. O’Neil, Călin Cainap, Eric Van Cutsem et al. · Clinical Colorectal Cancer · 2014 · 25 citations

Medicine, Oncology, Pharmacology +9